Viemed Healthcare Q1 2024 GAAP EPS $0.04 Misses $0.07 Estimate, Sales $50.593M Beat $50.000M Estimate
Viemed Healthcare Q1 2024 GAAP EPS $0.04 Misses $0.07 Estimate, Sales $50.593M Beat $50.000M Estimate
Viemed Healthcare 2024年第一季度GAAP每股收益0.04美元未达到0.07美元的预期，5,0593万美元的销售额超过5000万美元的预期
Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.07 by 42.86 percent. This is unchanged from the same period last year. The company reported quarterly sales of $50.593 million which beat the analyst consensus estimate of $50.000 million by 1.19 percent. This is a 27.90 percent increase over sales of $39.556 million the same period last year.
Viemed Healthcare（纳斯达克股票代码：VMD）公布的季度收益为每股0.04美元，比分析师普遍预期的0.07美元低42.86％。这与去年同期相比没有变化。该公司公布的季度销售额为5,0593万美元，比分析师普遍预期的5000万美元高出1.19％。这比去年同期的3,955.6万美元的销售额增长了27.90％。